ArticleJournal of managed care & specialty pharmacy2021
Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis.
Aliza R Karpes Matusevich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.